Company: SQFTP
Filing Date: 2025-08-14
Form Type: S-11
Source: 0001493152-25-011985
Chunk: 40

Company: Presidio Property Trust, Inc.
Filing Date: 2025-08-14
Form: S-11
Chunk 40
---
, we may purchase or lease income-producing commercial and other types of properties for long-term investment, expand and improve the properties we presently own or other acquired properties, or sell such properties, in whole or in part, when circumstances warrant.

We participate with third parties in property ownership, through limited liability partnerships or other types of co-ownership, and we may engage in such activities in the future if we determine that doing so would be the most effective means of owning or acquiring properties. We do not expect, however, to enter into limited liability partnership or other partnership arrangement to make an investment that would not otherwise meet our investment policies. We also may acquire real estate or interests in real estate in exchange for the issuance of common stock, preferred stock or options to purchase stock.

| 29 |

Equity investments in acquired properties may be subject to existing mortgage financing and other indebtedness or to new indebtedness which may be incurred in connection with acquiring or refinancing these investments. Principal and interest on our debt will have a priority over any dividends with respect to our common stock. Investments are also subject to our policy not to be required to register as an investment company under the Investment Company Act.

Securities of or Interests in Persons Primarily Engaged in Real Estate Activities and Other Issuers

Subject to the asset tests and
gross income tests necessary for REIT qualification, we may invest in securities of other REITs, other entities engaged in real estate
activities or securities of other issuers, including for the purpose of exercising control over such entities. We do not currently have
any policy limiting the types of entities in which we may invest or the proportion of assets to be so invested, whether through acquisition
of an entity’s common stock, limited liability or partnership interests, interests in another REIT or entry into a joint venture.
As of June 30 , 2025, we did not hold any marketable securities, excluding our investment in Conduit Pharmaceutical’s common
stock warrants. As of December 31, 2024 our marketable securities (excluding our investments in Conduit’s common stock and common
stock warrants), held at a third party broker, presented on the consolidated balance sheets within other assets were measured at fair
value using Level 1 market prices and totaled approximately zero, with a cost basis of approximately zero. There were no financial liabilities
measured at fair value as of June 30 , 2025 and December 31, 2024. We also held interests in two joint ventures. We have no current